Does BEVACIZUMAB-AWWB Cause Hyperglycaemia? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hyperglycaemia have been filed in association with BEVACIZUMAB-AWWB. This represents 0.2% of all adverse event reports for BEVACIZUMAB-AWWB.
6
Reports of Hyperglycaemia with BEVACIZUMAB-AWWB
0.2%
of all BEVACIZUMAB-AWWB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Hyperglycaemia From BEVACIZUMAB-AWWB?
Of the 6 reports, 1 (16.7%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Hyperglycaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB-AWWB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB-AWWB Cause?
Off label use (441)
Product storage error (437)
Circumstance or information capable of leading to medication error (346)
Hypertension (187)
Blood pressure increased (163)
Disease progression (160)
Product dose omission issue (158)
Adverse event (143)
Platelet count decreased (118)
Fatigue (104)
What Other Drugs Cause Hyperglycaemia?
INSULIN GLARGINE (1,903)
METFORMIN (1,626)
ALPELISIB (1,575)
DEXAMETHASONE (1,169)
PREDNISONE (1,135)
INSULIN LISPRO (743)
PREDNISOLONE (705)
INSULIN ASPART (646)
INSULIN HUMAN (620)
METHYLPREDNISOLONE (604)
Which BEVACIZUMAB-AWWB Alternatives Have Lower Hyperglycaemia Risk?
BEVACIZUMAB-AWWB vs BEVACIZUMAB-BVZR
BEVACIZUMAB-AWWB vs BEVACIZUMAB-MALY
BEVACIZUMAB-AWWB vs BEXAROTENE
BEVACIZUMAB-AWWB vs BEZAFIBRATE
BEVACIZUMAB-AWWB vs BEZLOTOXUMAB